Literature DB >> 21119285

Remission of Merkel cell tumor after somatostatin analog treatment.

M Fakiha1, P Letertre, J P Vuillez, J Lebeau.   

Abstract

We recently treated one patient presenting with a disseminated non-operable Merkel cell carcinoma (MCC) by lanreotide (somatostatin analog), with a complete remission of the disease and a follow up of 17 months. We present in this paper a case report with a review of the utilization of somatostatin analogues in the treatment of MCC.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21119285     DOI： 10.4103/0973-1482.73352

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN： 1998-4138            Impact factor:   1.805


  11 in total

1.  High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma.

Authors:  T Akaike; J Qazi; A Anderson; F S Behnia; M M Shinohara; G Akaike; D S Hippe; H Thomas; S R Takagishi; K Lachance; S Y Park; E S Tarabadkar; J G Iyer; A Blom; U Parvathaneni; H Vesselle; P Nghiem; S Bhatia
Journal:  Br J Dermatol       Date:  2020-06-16       Impact factor: 9.302

2.  Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.

Authors:  Natalie J Miller; Shailender Bhatia; Upendra Parvathaneni; Jayasri G Iyer; Paul Nghiem
Journal:  Curr Treat Options Oncol       Date:  2013-06

3.  Nuclear medicine techniques in Merkel cell carcinoma: A case report and review of the literature.

Authors:  Nikolaos Kritikos; Dimitrios Priftakis; Stavros Stavrinides; Stefanos Kleanthous; Eleni Sarafianou
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

Review 4.  Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Authors:  Daniela Femia; Natalie Prinzi; Andrea Anichini; Roberta Mortarini; Federico Nichetti; Francesca Corti; Martina Torchio; Giorgia Peverelli; Filippo Pagani; Andrea Maurichi; Ilaria Mattavelli; Massimo Milione; Nice Bedini; Ambra Corti; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

5.  Merkel cell carcinoma: a retrospective study on 48 cases and review of literature.

Authors:  Fernando Cirillo; Marco Vismarra; Ines Cafaro; Mario Martinotti
Journal:  J Oncol       Date:  2012-09-13       Impact factor: 4.375

6.  A practical update of surgical management of merkel cell carcinoma of the skin.

Authors:  Patricia Tai
Journal:  ISRN Surg       Date:  2013-01-30

Review 7.  Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options.

Authors:  Alok T Saini; Brett A Miles
Journal:  Onco Targets Ther       Date:  2015-08-19       Impact factor: 4.147

8.  Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?

Authors:  Guilherme Rabinowits
Journal:  Cancers (Basel)       Date:  2014-05-16       Impact factor: 6.639

9.  Merkel cell carcinoma: chemotherapy and emerging new therapeutic options.

Authors:  Laura Desch; Rainer Kunstfeld
Journal:  J Skin Cancer       Date:  2013-02-10

10.  The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma.

Authors:  Christian Adam; Anne Baeurle; Jeffrey L Brodsky; Peter Wipf; David Schrama; Jürgen Christian Becker; Roland Houben
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.